40
Participants
Start Date
April 17, 2017
Primary Completion Date
December 5, 2019
Study Completion Date
August 29, 2020
Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
One to two years after receiving the randomly-assigned vaccination, participants may opt to receive administration of a second pneumococcal vaccine with Pneumovax 23
Pneumococcal Vaccine Polyvalent
One to two years after receiving the randomly-assigned vaccination, participants may opt to receive administration of a second pneumococcal vaccine with Prevnar-13
UConn Center On Aging, Farmington
UConn Health
OTHER
University of Alabama at Birmingham
OTHER
The Jackson Laboratory
OTHER